$BSX · BOSTON SCIENTIFIC CORP SEC Filings
Position Tracker tracks 12 SEC EDGAR filings for BOSTON SCIENTIFIC CORP ($BSX) from August 5, 2026 through November 3, 2026, including 0 Form 10-K annual reports, 1 Form 10-Q quarterly earnings reports, 4 Form 8-K current event disclosures, and 6 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.
$BSX 10-Q — BOSTON SCIENTIFIC CORP
The 21% operating income drop on flat organic growth signals margin stress at a $64B medtech giant, compounded by litigation overhang and an unquantified cybersecurity incident.
$BSX 8-K — BOSTON SCIENTIFIC CORP
A $65B medtech giant guiding for negative sales growth in Q4 after a cybersecurity incident and booking $157M in YTD litigation charges is a rare double-hit that demands investo…
$BSX 8-K — Boston Scientific Corporation
Boston Scientific Corporation filed a Form 8-K on September 23, 2026, reporting that Arthur C. Butcher has decided to retire from his position as Executive Vice President and Gr…
$BSX 8-K — Boston Scientific Corporation
Boston Scientific filed a Current Report on Form 8-K on September 7, 2026, providing an update on a cybersecurity incident first reported on August 26, 2026. The incident, ident…
$BSX 4 — Boston Scientific Corporation
A Boston Scientific Corporation executive, Padraig Andrew O'Connor, reported a change in beneficial ownership on September 2, 2026. O'Connor, who serves as EVP of Global Operati…
$BSX 4 — Boston Scientific Corporation
This filing is a Form 4 statement of changes in beneficial ownership for Boston Scientific Corporation. It reports a transaction by Susan E. Morano, who is identified as a direc…
$BSX 8-K — Boston Scientific Corporation
Boston Scientific Corporation reported in a Form 8-K that on August 25, 2026, it identified a cybersecurity incident affecting certain of its information technology systems. The…
$BSX 4 — Boston Scientific Corporation
Boston Scientific Corporation filed a Form 4 on August 12, 2026, reporting a change in beneficial ownership for Emily Woodworth, the company's Senior Vice President, Global Cont…
$BSX 4 — Boston Scientific Corporation
A Form 4 filing from Boston Scientific Corporation, dated August 11, 2026, reports a change in beneficial ownership for Jonathan Monson, the company’s executive vice president a…
$BSX 4 — Boston Scientific Corporation
This SEC Form 4 filing reports a change in beneficial ownership by David C. Habiger, a director of Boston Scientific Corporation. On August 5, 2026, he purchased 2,100 shares of…
$BSX SC 13G/A — Boston Scientific Corporation
FMR LLC and Abigail P. Johnson filed Amendment No. 6 to a Schedule 13G regarding their holdings in Boston Scientific Corporation common stock. As of June 30, 2026, the reporting…
$BSX 4 — Boston Scientific Corporation
This SEC Form 4 filing reports that David C. Habiger, a director of Boston Scientific Corporation, acquired shares of the company's common stock in two separate open-market purc…